Search

Evidence is accumulating of the negative impact of the COVID‐19 pandemic and related public health measures on mental health. In this emergent field, there has been little research into the role of risk perception on depressive symptoms and the contribution of health‐care resources to model risk perception and mental health. The aim of this paper is to describe the relationship between individual‐level perception of risk and depression, controlling for a set of confounders and for country‐level heterogeneity. A cross‐sectional and observational online survey was conducted using a non‐probability snowball sampling technique. We use data on 11,340 respondents, living in six European countries (Italy, Sweden, United Kingdom, France, Poland, Czech Republic) who completed survey questionnaires during the first months of the pandemic. We used a fixed‐effect approach, which included individual and macro‐level variables. The findings suggest that a high proportion of people suffering from depression and heightened risk perception is positively associated with reporting depressive symptoms, even if this relationship varies significantly between countries. Moreover, the association is moderated by contextual factors including health‐care expenditure as a percentage of Gross Domestic Product, hospital beds for acute care, and number of medical specialists per head of population. Investment in health care offers a concrete means of protecting the mental health of a population living under pandemic restrictions. [ABSTRACT FROM AUTHOR]

Rationale: Public health and preventive medicine (PHPM) has been recognized internationally as a physician specialty, but national parallels and differences exist between training contexts. This paper reviews PHPM training and employment in Canada, France, Italy, Japan, the United Kingdom, and the USA. Methods: Information gathered from relevant accreditation bodies and literature searches was used to create descriptive profiles of national training demographics and structure and a narrative outlining trends and challenges facing the specialty. Results: Notable similarities and differences exist between national contexts. Key themes were differences in training strategies and practice scope, specialty stakeholders, certification structure, and funding. Recognition challenges faced the specialty across all six countries. Other challenges included unclear competencies and training strategies and a need for PHPM specialists to highlight their role in combating population health threats. Additional differences existed between comparator countries on the structure of training, funding sources for training programs, availability of training posts, and linkages with other physician specialties. Conclusion: Highlighting these themes is a first step to fostering training collaborations between PHPM specialist physicians to augment transnational action on global public health challenges and also supports PHPM physician educators with innovative solutions from abroad that might address domestic specialty challenges. [ABSTRACT FROM AUTHOR]

An introduction to the journal is presented in which the editor discusses various papers and articles including examining of public information management in Great Britain hospitals, performance evaluation in Italian public healthcare, and issues of the National Health Service deficits in England.

Objectives: The aim of the study was to assess the prevalence of oral contraceptive (OC) use, user characteristics and prescribing patterns by accessing health care databases of three European countries. Methods: A retrospective study was performed from 2009 to 2010 in three general practice (GP) databases from the Netherlands, UK and Italy and in one database of linked pharmacy and hospitalisation data in the Netherlands. The presence of selected chronic conditions and diagnoses of diseases associated with OC use were assessed, as were switches, discontinuations and types of OC used during the study period. Results: Among 2.16 million women aged 15 to 49 years, 16.0% were using an OC on 1 January 2010. The prevalence ranged from 19.7% in a Dutch database to 2.6% in the Italian database. During 2009 and 2010, mainly second-generation progestogens were prescribed in the Netherlands (79.4% and 78.3% of users), both second- (57.9%) and third-generation progestogens (43.6%) were prescribed in the UK, and mainly third-generation progestogens in Italy (61.8%). Most switches were to third- or fourth-generation pills. The prevalence of chronic diseases tended to be higher among OC users, and the proportions of women with a history of disease associated with OC use tended to be lower than among non-users. Conclusions: Second-generation OCs were most frequently prescribed in the Netherlands. In the UK, and even more so in Italy, many women used third- or fourth-generation OCs. Preparation switches were mainly to third- or fourth-generation OCs. Among OC users, a somewhat higher prevalence of chronic diseases was observed; however, information bias cannot be ruled out. 摘 要目的本研究的目的在于通过分析三个欧洲国家多个卫生数据库，评估口服避孕药的应用率、应用者的特征及处方类型。 方法本回顾性研究分析了2009年至2010年荷兰、英国与意大利的三个常规实践（GP）数据库，以及荷兰的一个药店连锁数据库与医院数据库。研究评估了某些与口服避孕药相关的慢性情况与疾病诊断，研究期间口服避孕药非连续性应用且种类多样。 结果研究包含216万名女性，年龄分布在15岁至49岁，其中16.0%的女性在2010年1月1日应用口服避孕药。应用率最高为荷兰数据库（19.7%），最低为意大利数据库（2.6%）。在2009年至2010年期间，荷兰女性主要应用第二代避孕药（分别有79.4%与78.3%的女性），英国女性应用第二代（57.9%）与第三代避孕药（43.6%），意大利女性主要应用第三代避孕药（61.8%）。最多的转换是第三代或第四代避孕药。服用口服避孕药的女性慢性病的发生率有升高的趋势，患有与口服避孕药相关病史的女性比例低于非口服避孕药女性。 结论二代口服避孕药是荷兰女性最常用的类型。在英国与大部分意大利女性，三代与四代口服避孕药应用更多。准备转换主要为三代与四代口服避孕药。在口服避孕药应用者中，观察发现慢性病的发生率更高，但不排除信息存在偏倚。 [ABSTRACT FROM PUBLISHER]